SCHEMBL3912927

SCHEMBL3912927

CC/C(=C\c1c(F)cc(OC)cc1F)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
HDAC1 Q13547 1/20 0.35
GRK6 P43250 1/20 0.35
LMNA P02545 1/20 0.35
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
PPARG P37231 1/20 0.34
CPS1 P31327 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3912929 1.00 POLB (0.38) POLBKMT2ATAAR1PSEN1PSEN2
SCHEMBL1746959 0.81 CYP1A1 (0.46) AKR1C3AKR1C2PPARGCPS1
SCHEMBL1587043 0.81 CYP1A1 (0.46) AKR1C3AKR1C2PPARGCPS1
SCHEMBL6361809 0.79 PTGS1 (0.40) POLBKMT2APSEN1PSEN2APH1B
SCHEMBL19972228 0.77 KDM4E (0.48) KMT2ALMNA
SCHEMBL19972225 0.77 KDM4E (0.48) KMT2ALMNA
SCHEMBL2555913 0.77 SMN1; SMN2 (0.41) LMNAPPARG
SCHEMBL2555914 0.77 SMN1; SMN2 (0.41) LMNAPPARG
SCHEMBL26292751 0.76 TBXAS1 (0.33) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2355224 0.74 LMNA (0.41) KMT2APSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585880-B2 Phenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-08 US disclosed
US-20070155808-A1 Phenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155808-A1 Phenylpropanoic acid derivatives GPR119, GPR55, FFAR1 POLB 4738/4885KMT2A 3549/4885TAAR1 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.